review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | R C Jagat Reddy | |
Thangadurai Maheswaran | |||
B Anand | |||
G S Asokan | |||
S Jeelani | |||
A Dany | |||
P2860 | cites work | Nanotheranostics for personalized medicine | Q26851449 |
Nanocarriers as an emerging platform for cancer therapy | Q29616699 | ||
Plasmonic nanobubbles as tunable cellular probes for cancer theranostics | Q30476207 | ||
Luminescent quantum dots for multiplexed biological detection and imaging | Q34114579 | ||
Nanoparticle-based theranostic agents | Q34130095 | ||
Pharmacogenetics and the concept of individualized medicine | Q34562770 | ||
Pharmacogenetics and pharmacogenomics: are they still promising? | Q35808353 | ||
Pharmacogenetics: using DNA to optimize drug therapy | Q36996458 | ||
Toward theragnostics | Q37356889 | ||
Theranostics and contrast-agents for medical imaging: a pharmaceutical company viewpoint | Q37441372 | ||
Pharmacogenomics, Theranostics and Personalized Medicine - the complexities of clinical trials: challenges in the developing world | Q37463850 | ||
Evaluation and validation of diagnostic tests for guiding therapeutic decisions | Q37578042 | ||
Personalized medicine: progress and promise | Q37896642 | ||
Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms. | Q37938830 | ||
Pharmacogenetics and personalized medicine: the future for drug prescribing. | Q39863675 | ||
Theranostic nanomedicine for cancer | Q80974270 | ||
Quo vadis personalized medicine? | Q88790196 | ||
P433 | issue | Suppl 1 | |
P304 | page(s) | S6-8 | |
P577 | publication date | 2014-07-01 | |
P1433 | published in | Journal of Pharmacy and Bioallied Sciences | Q6295744 |
P1476 | title | Theranostics: A treasured tailor for tomorrow | |
P478 | volume | 6 |
Q64251465 | A Review on (Hydro)Porphyrin-Loaded Polymer Micelles: Interesting and Valuable Platforms for Enhanced Cancer Nanotheranostics |
Q92327243 | Aptamers as Delivery Agents of siRNA and Chimeric Formulations for the Treatment of Cancer |
Q90415802 | Building sophisticated sensors of extracellular cues that enable mammalian cells to work as "doctors" in the body |
Q47135019 | Circulating Magnetic Microbubbles for Localized Real-Time Control of Drug Delivery by Ultrasonography-Guided Magnetic Targeting and Ultrasound |
Q38804858 | Concise review: Stem cell trials using companion animal disease models |
Q33820952 | Dual-Responsive Molecular Probe for Tumor Targeted Imaging and Photodynamic Therapy |
Q33914221 | Emerging proteomics biomarkers and prostate cancer burden in Africa. |
Q59794799 | Genomic Interventions in Medicine |
Q38492254 | Measuring pharmacogenetics in special groups: geriatrics |
Q64819927 | Neurotheranostics as personalized medicines |
Q26744936 | Personalized Medicine Based on Theranostic Radioiodine Molecular Imaging for Differentiated Thyroid Cancer |
Q90398425 | Personalized treatment options for thyroid cancer: current perspectives |
Q40967964 | Rapid Biosynthesis of Silver Nanoparticles Using Pepino (Solanum muricatum) Leaf Extract and Their Cytotoxicity on HeLa Cells. |
Q57370671 | Skin Cancer and Its Treatment: Novel Treatment Approaches with Emphasis on Nanotechnology |
Q98290880 | Smart Gold Nanostructures for Light Mediated Cancer Theranostics: Combining Optical Diagnostics with Photothermal Therapy |
Q52318555 | Steady-State Linear and Non-linear Optical Spectroscopy of Organic Chromophores and Bio-macromolecules. |
Q38836738 | Toward a world of theranostic medication: Programming biological sentinel systems for therapeutic intervention |
Q26746171 | Versatile Nanosystem-Based Cancer Theranostics: Design Inspiration and Predetermined Routing |
Search more.